24 August 2022
24 August 2022
One of the hallmarks of multiple myeloma (MM), a cancer of the bone marrow and one of the most frequent haematological cancers worldwide, is the disruption of the patients’ immune system, which allows the cancer to progress. Now, a study performed by Cristina João, who leads the Myeloma and Lymphoma Research Group at the Champalimaud Centre for the Unknown, and her colleagues, shows how so-called extracellular vesicles (EV’s) released by multiple myeloma cells can drive the disruption of the immune system.
16 August 2022
Adjuvant cancer treatments are the most conventional, most classic therapeutic approach to cancer. Here, the first step is usually surgery to remove the tumour, followed by chemotherapy, radiotherapy or other additional treatments to consolidate the surgery’s results.
09 Aug. 2022
We are seeking a highly motivated technician to support and assist in the operation and services of the Fish Platform of the Champalimaud Foundation. The selected candidate will join a dynamic and detail-oriented team with a strong team spirit.